3078Michigan State University College of Nursing.
5228University of Wisconsin Madison College of Nursing.
J Holist Nurs. 2022 Sep;40(3):265-280. doi: 10.1177/08980101211039086. Epub 2021 Sep 6.
Treatments for addressing psychiatric mental health issues in vulnerable patients with cancer are established. Yet, many patients persist with unrelenting psychological difficulties despite intervention. There is growing interest in the role of psilocybin-assisted psychotherapy for managing treatment-resistant mental health challenges in patients with cancer. Psilocybin is a naturally occurring compound derived from certain mushroom species that can induce entheogenic experiences or an altered state of consciousness. Reed's Self-Transcendence Theory provides a holistic lens to examine existential concerns and mental health in individuals who perceive their illness as potentially life threatening, such as those with cancer. This scoping literature review used Arksey and O'Malley's template to evaluate research examining psilocybin-assisted psychotherapy for patients with cancer. Eight articles met inclusion/exclusion criteria (four quantitative, two mixed methods, and two qualitative). Review findings indicated that the majority of patient experiences were positive, centering on themes of death acceptance, reflection, and broadened spirituality. Although psilocybin-assisted psychotherapy is in early stages of clinical testing, it thus shows promise for carefully screened patients with cancer who have persistent existential suffering. It will be critical for investigators to tailor this emerging intervention to select patients and for clinicians to be engaged in assessment of outcomes and efficacy.
针对癌症高危患者的精神心理健康问题已经确立了相应的治疗方法。然而,许多患者尽管接受了干预,但仍持续存在无法缓解的心理困扰。人们越来越关注使用迷幻蘑菇辅助心理治疗来应对癌症患者的治疗抵抗性心理健康挑战。迷幻蘑菇是一种从某些蘑菇物种中提取的天然化合物,能够引起致幻体验或意识改变状态。里德的自我超越理论为研究那些认为自己的疾病可能危及生命的个体(如癌症患者)的存在问题和心理健康提供了一个整体视角。本范围综述使用阿斯基和奥马利的模板评估了研究迷幻蘑菇辅助心理治疗对癌症患者的作用。有八项文章符合纳入/排除标准(四项定量研究,两项混合方法研究,两项定性研究)。综述结果表明,大多数患者的体验是积极的,主要集中在接受死亡、反思和精神拓宽等主题上。尽管迷幻蘑菇辅助心理治疗仍处于临床测试的早期阶段,但它为那些持续存在存在性痛苦的、经过精心筛选的癌症患者带来了希望。研究人员将这种新兴干预措施用于选择患者,以及临床医生评估结果和疗效将是至关重要的。